Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| Reeks: | Pediatric Neurology Briefs |
| Onderwerpen: | |
| Online toegang: | https://www.pediatricneurologybriefs.com/articles/632 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|